For Parents of a Child Whose Prescription Keeps Climbing
You are probably not shopping. You came home from another eye exam where the number went up again, someone handed you a new prescription without much explanation, and you started searching because it did not feel right that the answer is stronger glasses every year forever. That instinct is correct. This page explains what is actually happening in your child eye, what can and cannot be changed, and what we refuse to promise.
On this page
What You Are Actually Worried About
Why does my child need a stronger prescription every year?
Because the eyeball is growing longer. In a nearsighted child, the eye elongates faster than it should, which moves the retina further from where light focuses. Stronger lenses correct the resulting blur perfectly and do nothing about the elongation underneath. That is why the number keeps rising, and it is why correcting the blur is not the same as addressing the problem.
Here is the part usually left out of a routine exam. Axial elongation is permanent. Whatever length your child eye reaches, it keeps for life, and the associated risks scale with that final length rather than with how well the vision was corrected along the way.
Those risks are not hypothetical. Higher myopia is associated with meaningfully increased lifetime risk of retinal detachment, myopic maculopathy, glaucoma, and earlier cataract. Most people with myopia never experience any of them. But the probability rises with the degree of myopia, which is precisely why slowing progression during childhood is worth doing.
What Can and Cannot Be Changed
You deserve a clear line between the two, because a great deal of what is marketed to parents blurs it.
| Goal | Achievable? | What is actually true |
|---|---|---|
| Reverse the myopia already present | No | Axial elongation that has occurred is permanent. Nothing available reverses it. |
| Slow future progression | Often, meaningfully | Several evidence-based approaches reduce the rate of progression compared with single-vision correction. |
| Stop progression completely | Rarely | Slowing is realistic. Stopping is not something any responsible practice should promise. |
| Give clear vision without glasses today | Usually yes | This is the part Ortho-K does immediately and reliably for suitable candidates. |
Why the Prescription Is the Wrong Number to Watch
Every parent tracks the prescription because it is the number they are handed. It is a poor instrument for this job. It moves in quarter diopter steps, it varies with how tired your child is on exam day, and it can read flat for a full year while the eye is still lengthening underneath.
Axial length is the direct measurement of what actually changed. It is painless, takes moments, and produces a number in millimeters that can be plotted against expected growth for a child of that age. When you see the trend line, you stop guessing.
We measure it at baseline for every myopia control patient and remeasure on a defined schedule. Read axial length monitoring and progressive nearsightedness.
What One Visit Will Actually Tell You
You do not have to commit to anything to get useful information. A candidacy consultation produces four concrete answers.
- Where your child is now. Current refraction and a baseline axial length measurement, recorded so future visits have something to compare against.
- How fast they are moving. Combined with previous prescription records, if you bring them, a realistic picture of the rate of change.
- Whether Ortho-K is even possible. Corneal topography and an ocular surface assessment answer candidacy directly.
- What the alternatives are. If Ortho-K is not right, you leave knowing which other evidence-based options apply to your child.
Bring the last two or three prescriptions if you have them, even as photos on a phone. A history turns a snapshot into a trajectory, and a trajectory is what the decision actually rests on.
A candidacy consultation starts at $250 and is credited toward your program if you proceed. The complete Ortho-K program starts at $1,800, and ongoing annual myopia control monitoring starts at $1,200. You receive your exact figure in writing before you commit. See what is included in the consultation.
What We Will Not Promise You
- We will not promise a specific acuity. Some children reach excellent unaided vision. Some retain a small residual prescription.
- We will not promise your child will be a candidate. Corneal shape, prescription, and ocular surface health decide that, and we will tell you plainly if the answer is no.
- We will not promise progression will stop. Slowing is the realistic goal, and it is a worthwhile one.
If that sounds less confident than what you read elsewhere, that is the point. Read realistic expectations and clinical evidence, then decide.
What to Do This Week
- Find the old prescriptions. Two or three previous records turn a number into a trend.
- Get your child outside more. Two hours a day is the figure associated with benefit, and it starts today at no cost.
- Read the two pages that matter most. Childhood myopia management and Ortho-K for children.
- Book a baseline measurement. Even if you decide against treatment, a recorded baseline axial length makes every future decision better informed.
Frequently Asked Questions
Did screen time cause this?
Not on its own. Myopia development is driven by a combination of genetics and environment. Parental myopia is a strong predictor, and reduced time outdoors appears to matter more than screens specifically.
Near work of any kind, including books, is part of the picture. The practical advice that follows from the evidence is more outdoor time rather than eliminating screens.
Will my child grow out of it?
No. Myopia does not resolve on its own. It typically progresses through childhood and adolescence, then stabilizes in the late teens or early twenties.
The question worth asking is not whether it stops but where it stops, because the final degree of myopia is what carries the lifelong risk.
How much slower will progression be?
Published studies of Ortho-K in children report meaningful reductions in axial elongation compared with single-vision glasses or contacts, though the size of the effect varies between studies and between individual children.
We do not quote you a single percentage as if it were a guarantee. What we do is measure your child directly, so you see their actual response rather than a study average.
What are the alternatives to Ortho-K?
Low-dose atropine eye drops and specially designed soft multifocal or peripheral defocus contact lenses are the main evidence-based alternatives, and some children do best with a combination.
Each has a different profile of effectiveness, convenience, and side effects. See Ortho-K vs atropine for the comparison we walk parents through.
Is it too late if my child is already 13?
Usually not. Many children continue progressing into their mid and late teens, and if the eye is still changing there is still elongation worth slowing.
The absolute benefit is smaller than it would have been at eight, simply because less progression remains. That is an argument for starting now rather than for not starting. See myopia control for teens.
Keep reading
- Childhood Myopia ManagementThe full clinical picture of managing a progressing child.
- Axial Length MonitoringThe measurement that tells you whether control is working.
- Ortho-K for ChildrenWhat treatment looks like day to day for a 6 to 12 year old.
- Parent Guide to Ortho-KA practical walkthrough of the first three months at home.
- Ortho-K vs AtropineHow the two main myopia control approaches compare.
Last updated . Clinically reviewed by Dr. Mark Page.